Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
7.56
0.00 (0.00%)
At close: Jun 8, 2026, 4:00 PM EDT
7.63
+0.07 (0.89%)
After-hours: Jun 8, 2026, 6:54 PM EDT

CRBP Stock Forecast

Stock Price Forecast

According to 10 analysts polled by S&P Global, CRBP stock has a consensus rating of "Strong Buy" and an average price target of $36.5. The average 1-year stock price forecast is 382.80% higher than the current stock price, while the lowest is $17 (+124.87%) and the highest is $54 (+614.29%).

Price Target: $36.5 (+382.80%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$17$36.5$37$54
Change+124.87%+382.80%+389.42%+614.29%

Analyst Ratings

The average analyst rating for CRBP stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingDec '25Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy888988
Buy222111
Hold000000
Sell000000
Strong Sell000000
Total1010101099

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
William Blair
William Blair
Buy
Maintains
n/a
BuyMaintainsn/an/aJun 1, 2026
Mizuho Securities
Mizuho Securities
Buy
Reiterates
$44
BuyReiterates$44+482.01%May 27, 2026
Wedbush
Wedbush
Buy
Reiterates
$38$30
BuyReiterates$38$30+296.83%May 27, 2026
LifeSci Capital
LifeSci Capital
Buy
Maintains
$38
BuyMaintains$38+402.65%May 26, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$40
BuyReiterates$40+429.10%May 26, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
1.11M
Revenue Next Year
2.40M
from 1.11M
Increased by 116.00%
EPS This Year
-4.57
from -5.90
EPS Next Year
-5.07
from -4.57
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
881.71K----1.11M
Gross Profit
-35.56M-16.14M-31.17M-32.22M-70.10M1.11M
Gross Margin
-4,033.50%----100.00%
Operating Income
-55.99M-34.84M-45.08M-48.72M-85.31M-100.65M
Net Income
-45.64M-42.35M-44.60M-40.21M-78.54M-97.64M
EPS
-----5.90-4.57
Free Cash Flow
-39.01M-18.72M-21.27M-29.80M-37.73M-95.83M
No. Analysts
-----9
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High10.0M
Avg1.1M
Lown/a

Revenue Growth

Revenue Growth20272028
High
1,700.0%
Avg
116.0%
Low
-100.0%

EPS Forecast

EPS202620272028
High-
Avg-4.57
Low-

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-